| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.1 | 0.09 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.089 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.085 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.081 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.042 | 0.5 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.035 | 0.6 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.018 | 0.8 |